within Pharmacolibrary.Drugs.ATC.G;

model G04BX13
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.85,
    Cl             = 7.499999999999999e-07,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0006,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.005,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>G04BX13</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Dimethyl sulfoxide (DMSO) is an organosulfur compound that has anti-inflammatory, analgesic, and antioxidant properties. It has historically been used topically for the relief of pain and inflammation, particularly in interstitial cystitis and certain musculoskeletal disorders. DMSO is not widely used or approved as a drug in most countries today, with uses mostly limited to topical or intravesical (bladder) application.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult subjects. There is minimal published data on systemic pharmacokinetics; the values presented here are estimates based on historical data and secondary sources.</p><h4>References</h4><ol><li><p>Soma, LR, et al., &amp; Rudy, J (2018). Pharmacokinetics, disposition, and plasma concentrations of dimethyl sulfoxide (DMSO) in the horse following topical, oral, and intravenous administration. <i>Journal of veterinary pharmacology and therapeutics</i> 41(3) 384–392. DOI:<a href=\"https://doi.org/10.1111/jvp.12476\">10.1111/jvp.12476</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29333740/\">https://pubmed.ncbi.nlm.nih.gov/29333740</a></p></li><li><p>Özen, F, &amp; Eraslan, G (2022). Toxicokinetic of cyphenothrin in rabbits. <i>Environmental science and pollution research international</i> 29(21) 31541–31550. DOI:<a href=\"https://doi.org/10.1007/s11356-021-17775-x\">10.1007/s11356-021-17775-x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35001279/\">https://pubmed.ncbi.nlm.nih.gov/35001279</a></p></li><li><p>Gáll, Z, et al., &amp; Kolcsár, M (2015). Dose-dependent pharmacokinetics and brain penetration of rufinamide following intravenous and oral administration to rats. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 68 106–113. DOI:<a href=\"https://doi.org/10.1016/j.ejps.2014.12.012\">10.1016/j.ejps.2014.12.012</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25530452/\">https://pubmed.ncbi.nlm.nih.gov/25530452</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end G04BX13;
